止痛和抗炎药物混合物

💊 Pain Relief & Anti-Inflammatory Drug Mixture

🌐 HS Code Reference & Customs Clearance Guide | 2026 Updated Tariff Analysis | Professional Import Strategy
📌 One: Product Definition & Classification – What Exactly Is This Mixture?

This product is a combination pharmaceutical formulation designed to simultaneously provide analgesic (pain-relieving), antipyretic (fever-reducing), and non-steroidal anti-inflammatory (NSAID) effects. It typically contains two or more active ingredients (e.g., acetaminophen + ibuprofen, or aspirin + caffeine) in a single dosage form (tablet, capsule, syrup).

⚠️ Key Classification Point:
- If the mixture is not specifically listed under a more precise subheading and serves general pain, fever, and inflammation relief, it falls into the "other" category under broad therapeutic classifications.
- It is not classified as a specific antibiotic, hormone, or CNS drug — but rather as a multi-action symptomatic treatment.

📦 Two: HS Code Classification Details (2026 Updated Tariff Authority)

🔍 Critical Insight:
- 3004.90.92.34 is the most accurate for pain/fever/inflammation mixtures — it directly matches the functional profile. - 3004.90.92.33 applies when the product is classified under CNS drugs due to its mechanism of action (e.g., affecting brain pain centers). - 3003.90.01.90 & 3003.90.01.80 are backup categories if the mixture is not clearly anti-inflammatory but still contains multiple active ingredients.

💰 Three: 2026 Updated Tariff Breakdown (Including附加 Taxes & Legal Basis)

✅ Applicable Country: United States (US)
✅ Origin: China (CN)
✅ Effective Date: November 10, 2025 (inclusive of all future imports)

🎯 1. 3004.90.92.34 — Mixed Analgesic/Antipyretic/Anti-inflammatory Preparations

📌 Explanation:
- The 10% Section 122 tariff is a targeted trade measure applied to certain pharmaceuticals originating from China. - It is not a general Section 301 or IEEPA tariff, but a specific provision under the U.S. Trade Act of 1974, Section 122, which allows for additional duties on imports deemed to threaten national interest. - This applies only to non-specific, multi-ingredient drug mixtures not covered under more precise codes.

🎯 2. 3004.90.92.33 — CNS-Related Mixed Preparations (General Category)

📌 Note:
- This code applies when the product is classified under CNS drugs due to its central mechanism of action, even if it's not a controlled substance. - Same 10% rate as above — no difference in tariff, but different classification logic.

🎯 3. 3003.90.01.90 — Other Mixtures, Non-Specific Anti-Infective Use

📌 Use Case:
- Applies to non-antibiotic, multi-ingredient mixtures used for symptom relief (e.g., cold/flu combinations). - Even if not anti-infective, if the formulation is mixed, this code may apply.

🎯 4. 3003.90.01.80 — Mixtures of Two or More Components (Anti-Infective Use)

📌 Important:
- This is not limited to antibiotics — it includes any mixture of two or more active ingredients. - If your product is a combination of pain reliever + fever reducer + anti-inflammatory, this code may be used if no more specific category applies.

🛠️ Four: Customs Clearance Best Practices (Real-World Pro Tips)

✅ 1. Required Documentation (Must-Have Checklist)

✅ 2.申报技巧（Key Rules of Thumb）

🔥 “Match the function, pick the code, avoid the trap!”

✅ 3. Special Cases & Solutions

🌍 Five: Global Market Comparison (2026 Update)

📌 Key Takeaway:
- Only the U.S. applies the 10% Section 122 tariff on such mixtures. - China-origin products are most affected — no de minimis exemption. - EU, Japan, Australia have no additional tariffs — much more favorable.

📌 Six: Common Mistakes & How to Avoid Them (Learn from Others’ Errors)

❌ Mistake 1: Using 3004.90.92.33 for a product with no CNS mechanism
👉 Result: Classification mismatch → delayed clearance or penalties

❌ Mistake 2: Claiming "non-specific" but failing to prove mixture composition
👉 Result: Customs demands CoA → delayed release

❌ Mistake 3: Not including ingredient list on invoice
👉 Result: Rejection due to incomplete documentation

❌ Mistake 4: Using “cold medicine” as description without specifying pain/fever/inflammation role
👉 Result: Misclassified → incorrect tariff applied

✅ Correct Declaration Example:

“Combination Tablet: Acetaminophen 325mg + Ibuprofen 200mg + Caffeine 30mg – for pain, fever, and inflammation relief. Not an antibiotic. Mixed formulation. For oral use.”

🎯 Seven: Final Verdict – Smart Classification = Lower Risk, Higher Profit

🎯 Remember the Golden Rule:

🔹 “Function First, Code Second, Documentation Always!”
🔹 “10% in the U.S. is manageable — but only if you’re classified right!”

📌 Pro Tip:

If your product is originating from Vietnam, India, or Mexico, you may qualify for Section 122 exemption — 0% tariff!
✅ Apply for Advance Ruling (Pre-Approval) before shipment to avoid surprises.

📣 Take Action Now:

📞 Contact a licensed U.S. customs broker + Submit product specs + Request HS Code pre-ruling
🚀 Avoid 10% surprise taxes. Ship with confidence. Grow your global pharmacy business!

✨ Professional Clearance Starts with Precision.
💼 Your product’s success depends on one correct code — don’t gamble!